Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today announced that the U.S. Food and Drug Administration (FDA) ...
Roughly 25% to 50% of the total commercial nitrogen applied to fields across the state occurs in the fall. Waiting for cooler ...
Even though organ transplants are life-saving, due to blood-type compatibility, finding one can be tricky, but new research ...
Application based on positive results from Phase 3 PEGASUS study, which demonstrated statistically significant blood phenylalanine (Phe) lowering compared to diet ...
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the company's PALYNZIQ® (pegvaliase-pqpz) supplemental ...
Anyone who has experienced chronic pain knows how debilitating it can be. Just ask Daniele Piomelli, Ph.D., who has dealt ...
Spruce Biosciences Receives U.S. FDA Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) in Sanfilippo Syndrome Type B (MPS IIIB) Breakthrough Therapy ...
Understanding molecular diversity is fundamental to biomedical research and diagnostics, but existing analytical tools ...
Findings showed pegvaliase reduced mean blood Phe levels from baseline by 49.7% compared with 0.3% with diet only at week 72.
The authors suggested that steaming and microwaving retained higher concentrations of vitamin C than boiling because of the ...
A simple penciclovir cream may help cats with recurring eye infections. It keeps antiviral levels steady for hours, reducing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback